Trial intelligence / Profile preview

Five-year boostability after single-dose intramuscular rabies pre-exposure prophylaxis

NL-OMON60941Phase 4Recruiting

Sponsor
Leiden University Medical Center
Start
Sep 2024
Modality
Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label trial of Rabies vaccine in rabies (2 arms), sponsored by Leiden University Medical Center. Started Sep 2024; status: recruiting.

02

Drugs

Rabies vaccine
03

Conditions

rabies

Beyond the preview

Go deeper on NL-OMON60941.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON60941.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call